Skip to main content
. 2024 Feb 7;29(3):270–e413. doi: 10.1093/oncolo/oyad331

Table 7.

ITT mRECIST.

mRECIST Current mRECIST response Best mRECIST response
N Percent (95% CI) Counts Percent (95% CI)
ORR 9 36 (18%, 57.5%) 9 34.6 (17.2%, 55.7%)
CR 4 16 (4.5%, 36.1%) 4 15.4 (4.4%, 34.9%)
PR 5 20.0 (6.8%, 40.7%) 5 19.2 (6.6%, 39.4%)
SD 7 28.0 (12.1%, 49.4%) 15 57.7 (36.9%, 76.6%)
PD 9 36 (18%, 57.5%) 2 7.7 (0.9%, 25.1%)

Response based on 25 patients. Patients 1006, 1026, 1027, and 1031 have missing mRECIST. ITT Best mRECIST Based on 26 patients. Patients 1006, 1026, and 1031 have missing mRECIST.